Breztri Aerosphere (budesonide/glycopyrrolate) Patient Assistance Program
Don’t let the cost of Breztri Aerosphere endanger your health. We help eligible patients access this brand-name triple-therapy COPD inhaler for just $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) is FDA-approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Triple-therapy inhaler combining an inhaled corticosteroid (ICS), long-acting muscarinic antagonist (LAMA), and long-acting beta-agonist (LABA) in a single pressurized metered-dose inhaler.
- Without assistance, brand Breztri Aerosphere costs commonly run approximately $550–$750 per inhaler (typical 30-day supply).
- Through AffordMyPrescriptions, qualifying patients can access Breztri Aerosphere for a flat $69.95 per month.
- Other triple-therapy COPD inhaler: Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol — DPI, once daily). Dual LAMA-LABA combos (no ICS): Anoro Ellipta, Stiolto Respimat, Bevespi Aerosphere, Duaklir Pressair. ICS-LABA combos: Symbicort (going generic), Advair/Wixela Inhub (generic), Breo Ellipta, Dulera. Open triple via separate inhalers (typically generic) — cost-effective alternative when adherence allows.
What Is Breztri Aerosphere Prescription Assistance Program?
The Breztri Aerosphere Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Breztri Aerosphere (used for the maintenance treatment of COPD with a combination ICS/LAMA/LABA triple therapy) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but the enrollment process involves detailed applications, pulmonology coordination, supporting documentation, and ongoing renewal — which can be overwhelming when you are already managing COPD symptoms day-to-day.
At AffordMyPrescriptions, our Patient Advocates handle the entire Breztri Aerosphere PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your prescriber for required medical documentation, follow up with the manufacturer’s program until approval, manage your refills, and handle annual re-certification — so you never face a gap in your Breztri Aerosphere COPD treatment.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Breztri Aerosphere enrollment — from the initial application through ongoing refills and annual re-enrollment — so you never face a gap in your COPD treatment.
Pharmacy Price Comparison
- Without assistance, Breztri Aerosphere costs hundreds of dollars per inhaler at retail pharmacies. Discount cards and pharmacy coupons offer some relief, but they don't come close to what a Patient Assistance Program provides if you qualify. The table below compares typical retail pricing across major pharmacies to what you'd pay with our Breztri Aerosphere advocacy service:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$710/inhaler | Save ~$640/mo |
| CVS Pharmacy | ~$730/inhaler | Save ~$660/mo |
| Walmart | ~$700/inhaler | Save ~$630/mo |
| Costco | ~$680/inhaler | Save ~$610/mo |
| Kroger | ~$572/inhaler | Save ~$502/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Breztri Aerosphere — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Breztri Aerosphere Prescription Program?
The Breztri Aerosphere Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management — applications that are commonly delayed or denied when paperwork is incomplete. Our $69.95 per month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork. For some patients, open triple therapy using generic ICS plus generic LAMA-LABA components can substantially reduce costs when adherence to multiple inhalers is feasible.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Breztri Aerosphere:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
Coupon cards expire and require constant renewal
Still $550–$750/inhaler per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly from the manufacturer
- We manage all paperwork, refills, and renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Breztri Aerosphere assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Breztri Aerosphere Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Breztri Aerosphere:
Breztri Aerosphere delivers three COPD maintenance medications in a single pressurized metered-dose inhaler — an inhaled corticosteroid (budesonide), a long-acting muscarinic antagonist (glycopyrrolate), and a long-acting beta-agonist (formoterol). Indicated for COPD patients who need triple therapy to reduce exacerbations and improve symptoms.
How Breztri Aerosphere Works:
COPD involves chronic airflow obstruction, airway inflammation, mucus hypersecretion, and progressive lung damage. Frequent exacerbations accelerate decline and increase mortality risk.
Breztri Aerosphere addresses all three pathologic mechanisms simultaneously: budesonide (ICS) reduces airway inflammation, glycopyrrolate (LAMA) blocks muscarinic-mediated bronchoconstriction, and formoterol (LABA) provides sustained beta-2 bronchodilation. Single-inhaler triple therapy improves adherence vs multiple-inhaler regimens. GOLD guidelines recommend triple therapy for patients with frequent exacerbations on dual therapy.
Form and Use:
Breztri Aerosphere pMDI. 2 inhalations twice daily (morning and evening). Use with a spacer if preferred. Rinse mouth after use to reduce thrush risk. Shake before each use.
Generic Availability:
No generic Breztri Aerosphere. Other branded triple-therapy COPD inhaler: Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol — DPI, once daily). Dual LAMA-LABA combos: Anoro Ellipta (umeclidinium/vilanterol), Stiolto Respimat (tiotropium/olodaterol), Bevespi Aerosphere (glycopyrrolate/formoterol — same makers, no ICS), Duaklir Pressair (aclidinium/formoterol). Single-agent generics: tiotropium (Spiriva — generic now in some markets), albuterol HFA, ipratropium (Atrovent), short-acting combinations. ICS-LABA: Symbicort (going generic), Advair/Wixela Inhub (generic), Breo Ellipta, Dulera. Roflumilast (Daliresp generic) for severe COPD with chronic bronchitis. Pulmonary rehabilitation, smoking cessation, vaccination (influenza, pneumococcal, RSV) are foundational COPD care.
competition ensures that the price will remain elevated, making Patient Assistance Programs the most impactful savings pathway.
Warnings:
Paradoxical bronchospasm (discontinue if occurs), cardiovascular effects (tachycardia, arrhythmia, QT prolongation, ischemia — caution with cardiac disease), oral candidiasis (rinse mouth after use), increased pneumonia risk (ICS class effect in COPD), reduced bone mineral density, growth velocity reduction (pediatric — not approved), immunosuppression (caution with TB, fungal infections, varicella, HSV), hypokalemia, hyperglycemia, narrow-angle glaucoma worsening, urinary retention (LAMA effect — caution with BPH), milk-protein hypersensitivity, beta-blocker interactions, MAOI/TCA interactions.
FAQ (Frequently Asked Questions)
How Much Does Breztri Aerosphere Cost Without Insurance?
Brand Breztri Aerosphere $550–$750 per inhaler. AffordMyPrescriptions advocacy: $69.95 per month — savings of $500–$650 monthly compared to retail pharmacy pricing.
What is the difference between Breztri Aerosphere and Trelegy Ellipta?
Both are once-daily/twice-daily inhaled triple-therapy ICS/LAMA/LABA combinations for COPD. Breztri uses budesonide/glycopyrrolate/formoterol in a pMDI taken twice daily. Trelegy uses fluticasone furoate/umeclidinium/vilanterol in a DPI taken once daily. Both effective; choice often driven by insurance coverage, device preference, and adherence patterns.
Why does Breztri Aerosphere need to be rinsed out of my mouth after use?
The inhaled corticosteroid component (budesonide) can cause oral thrush (candidiasis) if it deposits on the oral mucosa. Rinsing your mouth with water and spitting after each use reduces this risk. Spacer use also reduces oropharyngeal deposition.
Is the pneumonia risk with Breztri Aerosphere real?
Yes — ICS-containing COPD inhalers increase pneumonia risk modestly in this population. The risk is balanced against reduced exacerbations and is acceptable for many patients. Discuss with your pulmonologist; in some COPD phenotypes (low eosinophils, no exacerbations), LAMA-LABA without ICS may be preferred.
Can I use open triple therapy with separate inhalers instead of Breztri Aerosphere?
Yes — generic ICS plus a generic LAMA plus a LABA (or LAMA-LABA combo) can achieve open triple therapy at substantially lower cost. Adherence is harder with multiple inhalers; single-inhaler therapy is generally preferred when affordable.
Is Breztri Aerosphere safe to take long-term?
Yes — designed for long-term maintenance COPD therapy. Monitor for ICS-related effects (thrush, bone density, pneumonia risk), cardiovascular tolerability, and clinical response (symptom control, exacerbation frequency). Continue smoking cessation, pulmonary rehabilitation, and vaccinations.
What happens if my Breztri Aerosphere Patient Assistance Program application is denied?
We help explore Trelegy Ellipta copay programs, open triple therapy with generic ICS + LAMA-LABA combos, manufacturer copay cards for commercial insurance, foundation aid (COPD Foundation, American Lung Association), Medicare Part D Extra Help, and pulmonary rehabilitation programs (covered by Medicare) that reduce exacerbations and improve quality of life.
Take Control of Your Medication Costs
COPD maintenance therapy should not be skipped over cost. Triple-therapy inhalers reduce exacerbations and improve symptoms — and assistance programs can make them affordable. Our Breztri Aerosphere advocacy team is ready to verify your eligibility, complete the manufacturer application on your behalf, and manage your prescription through approval, delivery, and renewal — for a flat $69.95 per month. If we cannot help you access Breztri Aerosphere through a Patient Assistance Program, you are not charged. Call (833) 556-2729 or check your eligibility online today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.